Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grottoli

Showing results (31-40 of 124) with videos related to

Pageof 13
Sort By:
Journal of Endocrinological Investigation|October 17, 2022
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiencyV Gasco, J Giannelli, L Campioni, et al.
European Journal of Endocrinology|November 1, 1994
Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal agingE Ghigo, E Arvat, G Rizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesityM Maccario, F Tassone, L Gianotti, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjectsE Arvat, L Gianotti, S Grottoli, et al.
Journal of Endocrinological Investigation|January 31, 2022
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance testF Bioletto, N Prencipe, A M Berton, et al.
Journal of Endocrinological Investigation|April 1, 1996
Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesityM Maccario, S Grottoli, M Procopio, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretionS Grottoli, M Procopio, M Maccario, et al.
Journal of Endocrinological Investigation|January 24, 1998
Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patientsS Grottoli, P Razzore, E Arvat, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factorsM Maccario, S Grottoli, M Procopio, et al.
European Journal of Endocrinology|September 1, 1995
Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humansE Arvat, L Gianotti, J Ramunni, et al.
Pageof 13

Showing results (31-40 of 124) with videos related to

Sort By:
Pageof 13
Journal of Endocrinological Investigation|October 17, 2022
Benefits of dual-release hydrocortisone treatment on central adiposity and health-related quality of life in secondary adrenal insufficiencyV Gasco, J Giannelli, L Campioni, et al.
European Journal of Endocrinology|November 1, 1994
Growth hormone-releasing activity of growth hormone-releasing peptide-6 is maintained after short-term oral pretreatment with the hexapeptide in normal agingE Ghigo, E Arvat, G Rizzi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Effects of recombinant human insulin-like growth factor I administration on the growth hormone (gh) response to GH-releasing hormone in obesityM Maccario, F Tassone, L Gianotti, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1994
Arginine and growth hormone-releasing hormone restore the blunted growth hormone-releasing activity of hexarelin in elderly subjectsE Arvat, L Gianotti, S Grottoli, et al.
Journal of Endocrinological Investigation|January 31, 2022
Optimal timing of blood samplings to detect GH inhibition during oral glucose tolerance testF Bioletto, N Prencipe, A M Berton, et al.
Journal of Endocrinological Investigation|April 1, 1996
Effect of bromocriptine on insulin, growth hormone and prolactin responses to arginine in obesityM Maccario, S Grottoli, M Procopio, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1997
In obesity, glucose load loses its early inhibitory, but maintains its late stimulatory, effect on somatotrope secretionS Grottoli, M Procopio, M Maccario, et al.
Journal of Endocrinological Investigation|January 24, 1998
Reduction of the somatotrope responsiveness to GHRH and Hexarelin but not to arginine plus GHRH in hyperprolactinemic patientsS Grottoli, P Razzore, E Arvat, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|September 21, 2000
The GH/IGF-I axis in obesity: influence of neuro-endocrine and metabolic factorsM Maccario, S Grottoli, M Procopio, et al.
European Journal of Endocrinology|September 1, 1995
Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humansE Arvat, L Gianotti, J Ramunni, et al.
Pageof 13